Pharma News

Keep updating your pharma knowledge
28 Dec 2014

Indian Biosimilar market valuation

Indian biosimilar market is around 2000 Crores.

Percentage of Biosimilar market over total pharma market

Biosimilar2.5%

Who are the leading players in Indian biosimilar market?

  • Biocon – Streptokinase, EPO Filgrastim, MAbs
  • Zydus – Insulin, Streptokinase, Filgrastim
  • DRL – Rituximab, Filgrastim, Darbepoetin alfa
  • Lupin – EGFR, Abciximab
  • Ranbaxy – EPO Filgrastim, Interferon, Infliximab
  • Wockhardt – Insulin, EPO, Insulin Glargine

 

 

 

 

1 Response

Leave a Reply


The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!